Temafloxacin in the treatment of male urethritis

Keizo Suzuki; Masaki Horiba; Toshiyuki Tanaka; Masahiro Yonezu; Yorio Naide; Hideo Hibi; Shin Ichi Ando; Koichi Ishiguro; Haruyoshi Asano; Kiyohito Ishikawa

doi:10.11250/chemotherapy1953.41.Supplement5_843

Temafloxacin in the treatment of male urethritis

Keizo Suzuki, Masaki Horiba, Toshiyuki Tanaka, Masahiro Yonezu, Yorio Naide, Hideo Hibi, Shin Ichi Ando, Koichi Ishiguro, Haruyoshi Asano, Kiyohito Ishikawa

Research output: Contribution to journal › Article › peer-review

Abstract

Twenty-one adult male outpatients with gonococcal (GUC) or chlamydial (NGU), and gonococcal/chlamydial (GCU/NGU) urethritis were treated with temafloxacin. It was given at a dose of 300~600 mg a day for 4~28 days (8.7 ±5.7 days). Eradication of the organisms was obtained for GCU in 14/14 (100%), NGU 3/3 (100%), and GCU/NGU 4/4 (100%). Clinically, the drug proved to be highly effective for male urethritis, and it was well tolerated by all patients treated.

Original language	English
Pages (from-to)	843-845
Number of pages	3
Journal	CHEMOTHERAPY
Volume	41
DOIs	https://doi.org/10.11250/chemotherapy1953.41.Supplement5_843
Publication status	Published - 1993
Externally published	Yes

All Science Journal Classification (ASJC) codes

Pharmacology (medical)
Infectious Diseases
Pharmacology
Drug Discovery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.11250/chemotherapy1953.41.Supplement5_843

Cite this

@article{c67ff6311fc7473c8a6cac2ba90fc78c,

title = "Temafloxacin in the treatment of male urethritis",

abstract = "Twenty-one adult male outpatients with gonococcal (GUC) or chlamydial (NGU), and gonococcal/chlamydial (GCU/NGU) urethritis were treated with temafloxacin. It was given at a dose of 300~600 mg a day for 4~28 days (8.7 ±5.7 days). Eradication of the organisms was obtained for GCU in 14/14 (100%), NGU 3/3 (100%), and GCU/NGU 4/4 (100%). Clinically, the drug proved to be highly effective for male urethritis, and it was well tolerated by all patients treated.",

author = "Keizo Suzuki and Masaki Horiba and Toshiyuki Tanaka and Masahiro Yonezu and Yorio Naide and Hideo Hibi and Ando, {Shin Ichi} and Koichi Ishiguro and Haruyoshi Asano and Kiyohito Ishikawa",

year = "1993",

doi = "10.11250/chemotherapy1953.41.Supplement5_843",

language = "English",

volume = "41",

pages = "843--845",

journal = "CHEMOTHERAPY",

issn = "0009-3165",

}

TY - JOUR

T1 - Temafloxacin in the treatment of male urethritis

AU - Suzuki, Keizo

AU - Horiba, Masaki

AU - Tanaka, Toshiyuki

AU - Yonezu, Masahiro

AU - Naide, Yorio

AU - Hibi, Hideo

AU - Ando, Shin Ichi

AU - Ishiguro, Koichi

AU - Asano, Haruyoshi

AU - Ishikawa, Kiyohito

PY - 1993

Y1 - 1993

N2 - Twenty-one adult male outpatients with gonococcal (GUC) or chlamydial (NGU), and gonococcal/chlamydial (GCU/NGU) urethritis were treated with temafloxacin. It was given at a dose of 300~600 mg a day for 4~28 days (8.7 ±5.7 days). Eradication of the organisms was obtained for GCU in 14/14 (100%), NGU 3/3 (100%), and GCU/NGU 4/4 (100%). Clinically, the drug proved to be highly effective for male urethritis, and it was well tolerated by all patients treated.

AB - Twenty-one adult male outpatients with gonococcal (GUC) or chlamydial (NGU), and gonococcal/chlamydial (GCU/NGU) urethritis were treated with temafloxacin. It was given at a dose of 300~600 mg a day for 4~28 days (8.7 ±5.7 days). Eradication of the organisms was obtained for GCU in 14/14 (100%), NGU 3/3 (100%), and GCU/NGU 4/4 (100%). Clinically, the drug proved to be highly effective for male urethritis, and it was well tolerated by all patients treated.

UR - http://www.scopus.com/inward/record.url?scp=0027761823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027761823&partnerID=8YFLogxK

U2 - 10.11250/chemotherapy1953.41.Supplement5_843

DO - 10.11250/chemotherapy1953.41.Supplement5_843

M3 - Article

AN - SCOPUS:0027761823

SN - 0009-3165

VL - 41

SP - 843

EP - 845

JO - CHEMOTHERAPY

JF - CHEMOTHERAPY

ER -

Temafloxacin in the treatment of male urethritis

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this